Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
Alok A Khorana,1 Mehul R Dalal,2 Jay Lin,3 Gregory C Connolly11Division of Oncology/Hematology, James P Wilmot Cancer Center, University of Rochester, Rochester, NY, 2sanofi-aventis US, Bridgewater, NJ, 3Novosys Health, Flemington, NJ, USABackground: This study examines venous thromboembolism (VTE)-...
Main Authors: | Khorana AA, Dalal MR, Lin J, Connolly GC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-02-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/health-care-costs-associated-with-venous-thromboembolism-in-selected-h-a12199 |
Similar Items
-
Prevention of venous thromboembolism in ambulatory patients with cancer
by: Marc Carrier, et al.
Published: (2020-12-01) -
Review of the cost of venous thromboembolism
by: Fernandez MM, et al.
Published: (2015-08-01) -
Evolving Treatment Options for Cancer-Related Venous Thromboembolism∗
by: Doaa Attia, MD, et al.
Published: (2020-09-01) -
Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review
by: Anne Rossel, et al.
Published: (2020-03-01) -
Prevention of venous thromboembolism in patients undergoing bariatric surgery
by: Bartlett MA, et al.
Published: (2015-08-01)